Colistin Therapy, Survival and Renal Replacement Therapy in Burn Patients: A 10-Year Single-Center Cohort Study

PURPOSE: Colistin is still a therapeutic cornerstone against multidrug-resistant gram-negative bacteria (MDRGN), mostly when other antibiotics do not gain adequate activity on these strains. In the present study, we evaluated in a cohort of burn patients the relationship between colistin therapy, su...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariano, Filippo, Malvasio, Valeria, Risso, Daniela, Depetris, Nadia, Pensa, Anna, Fucale, Giacomo, Gennari, Fabrizio, Biancone, Luigi, Stella, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150021/
https://www.ncbi.nlm.nih.gov/pubmed/35651672
http://dx.doi.org/10.2147/IJGM.S357427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150021/
https://www.ncbi.nlm.nih.gov/pubmed/35651672
http://dx.doi.org/10.2147/IJGM.S357427

Ejemplares similares